AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$16.82
Tradestie Score
46
Market Cap
$1.50B
P/E Ratio
7.4
Revenue Growth
0.2%
Analyst Upside
+7.0%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$31.12
|
$2.37B | 151.8 | 41 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.16
|
$2.34B | - | 39 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$74.40
|
$2.33B | - | 40 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$36.25
|
$2.33B | - | 45 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.50
|
$2.23B | - | 52 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.46
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$51.05
|
$2.21B | - | 75 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.06
|
$2.18B | - | 68 | Compare |
More AUPH Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry